Posts Tagged: USMCA
Amidst Push for a Summer Vote on USMCA, Report Argues RDP Requirement Would Not Raise Drug Prices
In the face of pressure to pull provisions in the United States-Mexico-Canada Agreement (USMCA) that would grant 10 years of regulatory data protection (RDP) for biologics inventions, a …
Other Barks & Bites for Friday, May 10: Congress and Trump Crack Down on Pharma, Amici File Briefs in Acorda, and USPTO to Modify Patent Term Adjustment Procedures
This week in Other Barks & Bites, IPWatchdog's IP news roundup: the House of Representatives passes drug patent legislation, while antitrust legislation targeting patent-related activities is introduced into …
Up and Running: Senate IP Subcommittee Debates USPTO Oversight After Setting Ambitious Agenda in February
Today, March 13, the Senate Subcommittee on Intellectual Property met to discuss “Oversight of the United States Patent and Trademark Office,” with USPTO Director Andrei Iancu as the …
A Vote for the USMCA Will Secure the Innovation of Tomorrow
Promoting public health has always been a bipartisan priority in Washington, D.C. Under the previous administration, lawmakers passed the 21st Century Cures Act and launched the …
U.S. Patent System Jumps to Tie for Second Place in International IP Index
On February 7, the U.S. Chamber of Commerce’s Global Innovation Policy Center (GIPC) released the latest version of its International IP Index assessing the intellectual property …
Canada Patent Law Changes Are Bad News for Patent Owners
The effects of changes made to Canada’s patent law at the end of 2018 won’t be fully clear for some time, but Canadian patent owners and …
